Literature DB >> 10671343

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

A Soriano1, J A Martínez, J Mensa, F Marco, M Almela, A Moreno-Martínez, F Sánchez, I Muñoz, M T Jiménez de Anta, E Soriano.   

Abstract

To assess whether methicillin resistance is a microbial characteristic associated with deleterious clinical outcome, we performed a cohort study on 908 consecutive episodes of Staphylococcus aureus bacteremia and a case-control study involving 163 pairs of patients matched for preexisting comorbidities, prognosis of the underlying disease, length of hospitalization, and age. Of 908 bacteremic episodes, 225 (24.8%) were due to methicillin-resistant S. aureus (MRSA). Multivariate analysis did not reveal that methicillin resistance was an independent predictor for mortality when shock, source of bacteremia, presence of an ultimately or rapidly fatal underlying disease, acquisition of the infection in an intensive care unit (ICU), inappropriate empirical therapy, female sex, and age were taken into account. Nonetheless, methicillin resistance was an independent predictor for shock. The case-control study could not confirm that shock was linked to MRSA when prior antimicrobial therapy, inappropriate treatment, ICU residence, and female sex were considered. Our data suggest that cohort studies tend to magnify the relationship of MRSA with clinical markers of microbial pathogenicity and that this effect is a shortcoming of these kind of studies that is caused by inadequate control for underlying diseases.

Entities:  

Mesh:

Year:  2000        PMID: 10671343     DOI: 10.1086/313650

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  64 in total

Review 1.  Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit.

Authors:  A S Haddadin; S A Fappiano; P A Lipsett
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

2.  Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia.

Authors:  Ganesh Kumarachandran; Jennifer Kristie Johnson; Debbie-Ann Shirley; Eileen Graffunder; Emily L Heil
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

3.  Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Sung-Han Kim; Kye-Hyung Kim; Hong-Bin Kim; Nam-Joong Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

4.  Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.

Authors:  J John Weems; James P Steinberg; Scott Filler; John W Baddley; G Ralph Corey; Priya Sampathkumar; Lisa Winston; Joseph F John; Christine J Kubin; Rohit Talwani; Thomas Moore; Joseph M Patti; Seth Hetherington; Michele Texter; Eric Wenzel; Violet A Kelley; Vance G Fowler
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?

Authors:  J Kehrmann; M Kaase; F Szabados; S G Gatermann; J Buer; P-M Rath; J Steinmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-13       Impact factor: 3.267

6.  Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Authors:  Roopa Ganga; Kathleen Riederer; Mamta Sharma; Mohamad G Fakih; Leonard B Johnson; Stephen Shemes; Riad Khatib
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

7.  Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Nicholas S Britt; Nimish Patel; Rebecca T Horvat; Molly E Steed
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.

Authors:  Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; George Sakoulas; Eli N Perencevich
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

9.  A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis.

Authors:  Hee Jung Yoon; Jun Yong Choi; Chang Oh Kim; June Myung Kim; Young Goo Song
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

10.  Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study.

Authors:  Shingo Chihara; Kyle J Popovich; Robert A Weinstein; Bala Hota
Journal:  BMC Infect Dis       Date:  2010-07-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.